The last six volunteers of the first-phase SARS clinical trial have been inoculated with the anti-SARS vaccine and are currently in stable condition.

An official responsible for the trial says that the last group of volunteers began the test last Wednesday, and all of them maintain normal body temperature after a week of observation, crienglish.com reported Wednesday.

So far, all 36 volunteers of the first-phase SARS clinical trial have been inoculated with the vaccine, and none of them appear to be suffering from adverse side effects.

The trial started in April and involved 18 males and 18 females aged from 21 to 40.

(CRI August 11, 2004)